Le Lézard
Classified in: Science and technology, Business
Subjects: CCA, ERP, FVT

IQST - iQSTEL Shatters 2023 $120 Million Revenue Forecast Reaching $140 Million


NEW YORK, Jan. 5, 2024 /PRNewswire/ -- iQSTEL Inc. (OTC-QX: IQST) today announced exceeding its 2023 $120 million annual revenue forecast reaching $140 million based on preliminary accounting.  The company's gross margin also continued to grow in Q4 after the operating income turned positive ahead of schedule in Q3. iQSTEL management plans to revise its original $145 million 2024 annual revenue forecast upward in light of today's announcement.  The company recently filed a Definitive Proxy Statement in conjunction with an upcoming annual shareholder meeting scheduled on Wednesday January 31, 2024, at 10 am (EST).  Look for more news coming soon in advance of the shareholder meeting.

About IQSTEL:

iQSTEL Inc. (OTC-QX: IQST) (www.iQSTEL.com) is a US-based, multinational publicly listed company preparing for a Nasdaq up-listing with an FY2023 $120 million revenue forecast. iQSTEL's mission is to serve basic human needs in today's modern world by making the necessary tools accessible regardless of race, ethnicity, religion, socioeconomic status, or identity.  iQSTEL recognizes that in today's modern world, the pursuit of the human hierarchy of needs (physiological, safety, relationship, esteem and self-actualization) is marginalized without access to ubiquitous communications, the freedom of virtual banking, clean affordable mobility and information and content. iQSTEL has 4 Business Divisions delivering accessibly to the necessary tools in today's pursuit of basic human needs: Telecommunications, Fintech, Electric Vehicles and Metaverse.

The company continues to grow and expand its suite of products and services both organically and through mergers and acquisitions.  iQSTEL has completed 10 acquisitions since June 2018 and continues to develop an active pipeline of potential future acquisitions.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

iQSTEL Inc.
IR US Phone: 646-740-0907
IR Email: [email protected]

Contact Details
iQSTEL Inc.
+1 646-740-0907
[email protected]

Company Website
www.iqstel.com

Logo - https://mma.prnewswire.com/media/1308745/4480026/iQSTEL_Logo.jpg

SOURCE iQSTEL Inc.


These press releases may also interest you

at 22:00
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell...

at 21:30
XREX Singapore, a blockchain-enabled financial institution specialising in cross-border payments in emerging markets, announced today that it has obtained the Major Payment Institution (MPI) Licence from the Monetary Authority of Singapore (MAS), the...

at 21:25
The second installment of the China International Supply Chain Promotion Expo recently staged its roadshow in Budapest, Hungary. The event saw the participation of Ren Hongbin, Chairman of the China Council for the Promotion of International Trade...

at 21:00
LG Electronics' (LG) CEO, William Cho, has embarked on a strategic business trip to the tech-rich western United States, a hotspot for global tech titans and dynamic AI dialogues. Throughout his week-long visit, Cho will focus on key tasks such as...

at 20:25
Zai Lab Limited today announced that the National Medical Products Administration (NMPA) in China has approved the New Drug Application (NDA) for AUGTYROtm (repotrectinib) for the treatment of adult patients with locally advanced or metastatic...

at 20:05
PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a steadfast commitment to enhancing animal patient wellbeing and accelerating healing, PBC BioVet is poised to...



News published on and distributed by: